Entrar/Registro  
HOME SPANISH
 
Cirugía y Cirujanos
   
MENU

Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board






>Journals >Cirugía y Cirujanos >Year 2008, Issue 1


Curiel-Valdés JJ
The diagnosis of human papiloma virus in the context of a vaccine
Cir Cir 2008; 76 (1)

Language: Español
References: 13
Page: 1-3
PDF: 41.36 Kb.


Full text




Text Extraction

No abstract


Key words: No keywords


REFERENCIAS

  1. Wright TC, Van Dame P, Schmitt HJ, Meheus A. HPV vaccine introduction in industrialized countries. Vaccine 2006;24S3:122-131.

  2. 2. Kane MA, Sherris J, Coursaget P, Aguado T, Cutts F. HPV vaccine use in the developing world. Vaccine 2006;24(Suppl 3):132-139.

  3. 3. Lazcano-Ponce E, Rivera L, Arillo-Santillán E, Salmerón J, Hernández-Ávila M, Muñoz N. Acceptability of a human papilllomavirus (HPV) trial vaccine among mothers of adolescents in Cuernavaca, Mexico. Arch Med Res 2001;32:243-247.

  4. 4. Paavonen J, Jenkins D, Bosch FX, et al. Efficacy of a prophylactic adjuvant bivalent L1 virus-like particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double blind, randomized control trial. Lancet 2007;369:2161-2170.

  5. 5. Loustalot M. Presentado en congreso de Acapulco 17 a 21 de julio 2007.

  6. 6. Curiel-Valdés JJ. Biopsia de cérvix: ¿Es confiable y reproducible el diagnóstico histológico? La utilidad de p16 INK4A para lograrlo. Ginecol Obstet Mex 2007;75:615-620.

  7. 7. Moscicki AB, Schiffman M, Kjaer S, Villa L. Updating the natural history of HPV and anogenital cancers. Vaccine 2006;24S3:42-51.

  8. 8. Stanlet M, Lowy D, Frazer I. Prophylactic HPV vaccines: underlying mechanisms. Vaccine 2006;24(Suppl 3):106-113.

  9. 9. Parkin DM, Bray F. The burden of HPV-related cancers. Vaccine 2006;24(Suppl 3):11-25.

  10. 10. Kitchener HC, Castle PE, Cox T. Achievements and limitations of cervical cytology screening. Vaccine 2006;24(Suppl 3):63-70.

  11. 11. Klaes R, Brenner A, Friedich T, et al. P16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 2002;26:1389-1399.

  12. 12. Kong CS, Balzer BL, Troxell ML, Patterson BK, Longacre TA. P16INK4a immunohistochemistry is superior to HPV in situ hybridization for detection of high-risk HPV in atypical squamous metaplasia. Am J Surg Pathol 2007;31:33-42.

  13. 13. Agoff SN, Lin P, Morihara J, et al. P16INK4a expression correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high-risk HPV types. Mod Pathol 2003;16:665-673.






>Journals >Cirugía y Cirujanos >Year 2008, Issue 1
 

· Journal Index 
· Links 






       
Copyright 2019